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Abstract
Interleukin-17 (IL-17) producing T helper cells (TH-17) comprise a newly recognized T cell subset with an emerging role in
adaptive immunity to a variety of fungi. Whether different airborne fungi trigger a common signaling pathway for TH-17
induction, and whether this ability is related to the inherent pathogenic behavior of each fungus is currently unknown. Here
we show that, as opposed to primary pathogenic fungi (Histoplasma capsulatum), opportunistic fungal pathogens
(Aspergillus and Rhizopus) trigger a common innate sensing pathway in human dendritic cells (DCs) that results in robust
production of IL-23 and drives TH-17 responses. This response requires activation of dectin-1 by the fungal cell wall
polysaccharide b-glucan that is selectively exposed during the invasive growth of opportunistic fungi. Notably, unmasking
of b-glucan in the cell wall of a mutant of Histoplasma not only abrogates the pathogenicity of this fungus, but also triggers
the induction of IL-23 producing DCs. Thus, b-glucan exposure in the fungal cell wall is essential for the induction of IL-23/
TH-17 axis and may represent a key factor that regulates protective immunity to opportunistic but not pathogenic fungi.
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Introduction
In recent years, opportunistic fungal pathogens have become
major causes of life-threatening infections in an expanding
population of severely immunocompromised individuals, as a
result of the increasing use of transplantation, the development of
immunosuppressive therapies for autoimmune and neoplastic
diseases, and the AIDS pandemic [1,2]. In these patients,
Aspergillus is the predominant fungal pathogen [3], whereas
Zygomycetes have emerged as the second most common cause
of opportunistic mold infections [4,5]. Infections caused by these
fungi have a poor prognosis with mortality rates exceeding 90%
upon dissemination, mainly because of their inherent resistance to
existing antifungal agents [1–5]. Thus, there is a need for better
understanding of the pathogenesis of opportunistic fungal
infections in order to develop novel therapeutic strategies.
T helper (TH) cells play a crucial role in host defense against
fungi through the secretion of distinct cytokine profiles [6,7].
Traditionally, responses by interferon-c (IFN-c)–producing TH-1
cells are considered to confer protective immunity against fungi,
whereas TH-2 responses mediated by IL-4 lead to increased
susceptibility to fungal infections [6,7]. More recently, a subset of
TH cells, called IL-17-producing TH (TH-17) cells, have been
identified and implicated in mucosal immunity against extracel-
lular bacteria [8,9] and fungi [10-17]. In particular, IL-17 receptor
deficient mice are susceptible to disseminated [10] and oropha-
ryngeal [11] candidiasis, whereas impaired IL-17 production has
been associated with increased susceptibility to fungal pneumonia
caused by Pneumocystis [12], Cryptococcus [13], and Aspergillus ([14].
In humans, patients with mutations in STAT3 have selective
impairment of IL-17 producing T cells and are prone to infections
with invasive fungal pathogens, including Candida and Aspergillus
[15]. Furthermore, Candida-specific human memory CD4
+ T cells
belong to the TH-17 subset [16], and are significantly decreased in
patients with chronic mucocutaneous candidiasis [17].
IL-23, a member of the IL-12 cytokine family, has a master role
in regulating TH-17 development [8,9,18]. Dendritic cells (DCs)
are the main source of IL-23, which is secreted as a heterodimer
comprising of a p19 subunit and a p40 subunit shared with IL-12
[18]. Human TH-17 cells originate from CD161
+ T-cell precursors
that constitutively express IL-23R [19], and naı ¨ve CD4
+ T cells
differentiate in vitro into mature TH-17 cells in response to the
combined activity of IL-23 and IL-1b in the presence of TGF-b
[19–22].
In contrast to IL-23, IL-12 is associated with the differentiation
of naı ¨ve CD4
+ T cell into IFN-c secreting TH-1 cells [8,9,18].
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receptors that drive the differentiation of DCs into producers of
either IL-12 or IL-23 [8,9,23]. In fungi, activation of members of
the Toll-like receptor (TLR) family, mainly TLR2 and TLR4, in
DCs has been linked to the induction of IL-12 leading to
protective TH-1 responses against Candida and Aspergillus [24,25].
On the other hand, activation of dectin-1, a C-type lectin expressed
on DCs that recognizes the polysaccharide b-glucan, triggers the
induction of IL-23 through the syk-CARD-9 signaling pathway
[26], and drives robust TH-17 response [26]. Interestingly, while
the yeast form of Candida albicans induces IL-12, the invasive,
tissue-infiltrating form of the fungus (hyphae) selectively induces
IL-23 and drives TH-17 responses [26]. Therefore, it appears that
tissue invasion by fungi triggers activation of the IL-23/TH-17
pathway that has a central role in the initiation of an acute
inflammatory response via neutrophil recruitment and the
induction of epithelial antimicrobial peptides [6,7]. The important
role of dectin-1-syk-CARD-9 signaling in induction of TH-17
responses and protective mucosal immunity against Candida has
been convincingly shown both in mice [27,28] and recently in
humans [29,30].
In view of the complexity and the structural differences in the
fungal cell wall of fungi [31,32], whether activation of dectin-1
signaling is a major pathway for TH-17 induction in response to
airborne opportunistic fungal pathogens that currently cause the
majority of fungal infections in immunocompromised patients, and
whether this ability is related to specific growth stages and/or the
inherent pathogenic behavior of each fungus in currently
unknown.
Here we studied human DC responses against the two
predominant airborne opportunistic fungal pathogens, Aspergillus
and Rhizopus, and the pathogenic fungus Histoplasma. Importantly,
we found that opportunistic fungal pathogens (Aspergillus and
Rhizopus) but not primary pathogenic fungi (Histoplasma) prime
dendritic cells (DCs) to produce high levels of IL-23, which drives
TH-17 responses. The induction of these IL-23 producing DCs
depended on activation of dectin-1 and is mediated by b-glucan
exposed in the cell wall of the invasive form of opportunistic fungal
pathogens. By contrast, the yeast form of the pathogenic fungus
Histoplasma, which lacks cell wall exposure of b-glucan, failed to
induce IL-23 producing DCs. Notably, unmasking of b-glucan in
the cell wall of a mutant of Histoplasma, not only abrogated the
pathogenicity of this fungus, but also triggered the induction of IL-
23 producing DCs. Thus, b-glucan exposure in the cell wall of
fungi is essential for the generation of IL-23 producing DCs and
TH-17 immune responses and may represent a key factor that
regulates protective immunity to opportunistic but not primary
pathogenic fungi.
Results
The invasive stage of growth of opportunistic fungal
pathogens but not that of primary pathogenic fungi
drives the induction of IL-23 producing DCs
To test the ability of airborne fungi that cause human infections
to drive DC-mediated TH-17 responses, we used Aspergillus and
Rhizopus as model opportunistic fungal pathogens and Histoplasma,
a pathogenic fungus that causes infections in immunocompetent
individuals [6]. Previous studies suggested that DCs are capable of
discriminating between the different stages of fungal growth
(spores vs. hyphae) to prime the development of TH-1 and TH-2
responses [24,25]. We therefore tested if the induction of TH-17
responses is also dependent on specific stage of growth of fungi by
human DCs. Human DCs were infected with invasive stage
(hyphae) or the resting stage (spores) of Aspergillus or Rhizopus, and
cytokine secretion was analyzed after overnight culture. We found
that DC infected with the invasive stage but not the resting stage of
both fungi secreted high amounts of IL-23 (Figure 1A) and only
low amounts of IL-12 (Figure 1B). Importantly, IL-23 production
by DCs has been recognized to be a key driver of TH-17 responses
[8,9,19,23]. IL-23 producing DCs induced by the invasive stage of
Aspergillus or Rhizopus also secreted high levels of IL-1, IL-6, and
TNF-a (Figure S1).
Next, we evaluated DCs infected with the pathogenic fungus
Histoplasma, one of the few fungi that cause invasive infections in
immunocompetent individuals [6,32]. Histoplasma is a dimorphic
fungus that adapts a particular stage of growth (yeast) at
mammalian temperatures [6,32]. This growth adaptation is
considered a virulence trait of Histoplasma that allows the fungus
to escape immune recognition and establish persistent infection
within host macrophages [32]. Interestingly, in contrast to
opportunistic fungi, we found that the yeast form of Histoplasma
failed to elicit IL-23 producing DCs (Figure 1A). Together, these
data demonstrate that the invasive form of opportunistic fungal
pathogens Aspergillus or Rhizopus but not of the pathogenic fungus
Histoplasma drives the induction of IL-23 producing DCs.
The invasive form of opportunistic fungal pathogens but
not that of primary pathogenic fungi exposes b-glucan in
the cell wall surface
b-glucan has been shown to be a key driver of IL-23 production
in DCs [23,26]. Previous studies have shown that Aspergillus
exposes b-glucan on the cell wall surface during the invasive stage
of growth (hyphae) [33–35]. Thus, we sought to determine
whether like Aspergillus also Rhizopus but not Histoplasma exposes b-
glucan in the cell wall of the invasive stage of fungal growth.
Immunofluorescene studies using a b-glucan specific monoclonal
antibody confirmed the exposure of b-glucan in hyphae of
Aspergillus (Figure 2). Interestingly, abundant staining of b-glucan
was also found on the surface of hyphae of Rhizopus (Figure 2),
which is in contrast to previous reports that failed to identify b-
glucan on the cell wall of Rhizopus and instead suggested that chitin
and chitosan comprise the main polysaccharides of this fungus
[36]. Importantly, there was no evidence of b-glucan staining in
the spores of both opportunistic fungal pathogens and in the yeast
form of the pathogenic fungus Histoplasma (Figure 2). These data
indicate that b-glucan exposure selectively occurs in the invasive
stage of growth of opportunistic fungal pathogens but not in
primary pathogenic fungi, a finding that correlates with the ability
of these fungi to induce IL-23 producing DC.
Induction of IL-23 producing DCs by opportunistic fungal
pathogens is dectin-1 dependent and is mediated by
b-glucan
Next, we sought to demonstrate that the selective exposure of b-
glucan in the hyphae of opportunistic fungal pathogens drives the
induction of IL-23 producing DCs. We used laminarin, a
competitive inhibitor of b-glucan for its binding to dectin-1, the
receptor for b-glucan expressed on DCs [27,37]. Increasing
concentrations of laminarin abrogated the induction of IL-23
production by DCs infected with hyphae of Aspergillus or Rhizopus
(Figure 3A). As a control, we stimulated DCs with the TLR4
agonist LPS, and showed that laminarin had no effect on the
production of IL-23 by DCs (Figure S2). Furthermore, pre-
incubation of DCs with a neutralizing anti-dectin-1 antibody
resulted in complete inhibition of IL-23 production in DCs
infected with hyphae of both opportunistic fungi, while it had no
IL-23 Regulates Virulence
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(Figure 3B).
Because b-glucan is not the only ligand of dectin-1 [37,38], we
further investigated the role of b-glucan surface exposure by specific
enzymatic digestion of b-glucan in the fungal cell walls using b-
glucanase. The ability of b-glucanasetodigestb-glucaninthecellwall
of hyphae of Aspergillus and Rhizopus was confirmed by immunofluor-
escene studies (Figure 3C). DCs infected with b-glucanase-treated
hyphae were unable to produce any IL-23 (Figure 3D), indicating
that hyphae of opportunistic fungal pathogens induce IL-23
producing DCs through b-glucan surface exposure.
Enforced b-glucan surface exposure in the
non-pathogenic Histoplasma Dags1 mutant drives
IL-23 producing DCs
In contrast to opportunistic fungal pathogens, in Histoplasma
cell wall immunostimulatory b-glucans are covered in the yeast
(infectious) form of the fungus by a layer of a-(1–3)-glucan [32,39].
Concealing of b-glucan by non-stimulatory a-(1–3)-glucan mole-
cules is regarded as a virulence mechanism, because it allows
Histoplasma to avoid immune recognition and survive within the
host cells. As a proof of principle, b-glucan surface exposure in the
Dags1 mutant of Histoplasma capsulatum that lacks a-(1–3)-glucan,
renders it non-pathogenic in mice and results in increased release
of TNFa in infected mouse macrophages through dectin-1
activation [39].
We hypothesized that similar to the induction of IL-23 release
by b-glucan exposure in the hyphae of opportunistic fungal
pathogens, unmasking of b-glucan in the Dags1 mutant of
Histoplasma should trigger the release of IL-23 in human DCs.
We initially confirmed by immunofluorescene studies that the
yeast form of the Dags1 mutant of Histoplasma had surface exposure
of b-glucan as opposite to its isogenic complementary Ags1+ strain
(Figure 4A). Importantly, infection of human DCs with the yeast
form of the Dags1 mutant of Histoplasma resulted in the production
of IL-23 (Figure 4B); in contrast, there was no IL-23 production in
DCs infected with the isogenic complementary Ags1+ strain of
Histoplasma (Figure 4B). Additionally, IL-23 production by human
DCs infected with the Dags1 mutant was inhibited following
blocking of dectin-1 receptor or enzymatic digestion of b-glucan
(Figure 4B). These results further support the role of b-glucan in
driving IL-23 producing DCs and indicate that the exposure of cell
wall b-glucans may restrict the pathogenic potential of fungi via
the induction of the IL-23-TH-17 response pathway.
IL-23 producing DCs induced by opportunistic fungal
pathogens drive TH-17 responses
Because IL-23 producing DCs represent the key drivers of TH-
17 responses (8, 9, 19, 23), we next sought to determine whether
human DCs stimulated with opportunistic fungal pathogens are
capable of driving TH-17 responses. Purified human naı ¨ve and
memory CD4
+ T cells were activated polyclonally in the presence
of supernatants of DCs previously stimulated with hyphae or
spores of Aspergillus. DCs stimulated with hyphae but not spores of
Aspergillus induced a predominant increase in IL-17 production
versus IFN-c, indicating that the invasive form of this fungus can
trigger DC-mediated TH-17 responses (Figure 5A). This finding
was confirmed by intracellular cytokine staining of primed CD4
+
T cells (Figure 5B), as there was a significant increase in IL-17
+/
IFN-c
2 single positive CD4
+ T cells (mean increase from 4.6% to
9,7%, n=5 experiments; P=0.004) and IL-17
+/IFN-c
+ double
positive CD4+ T cells (mean increase from 1,1% to 9,7%; n=5
experiments; P=0.002), (Figure S4).
Figure 1. The invasive stage of growth of opportunistic fungal
pathogens but not that of primary pathogenic fungi drives the
induction of IL-23 producing DCs. IL-23 (A) and IL-12 (B) produced
by human monocyte-derived DCs (1610
6 cells per ml) following
overnight stimulation with purified b-glucan (curdlan, 100 mg/ml), LPS
(100 ng/ml), resting (spores) or invasive (hyphae) stages of growth of
each opportunistic fungal pathogen (Aspergillus and Rhizopus) and the
invasive form (yeast) of the pathogenic fungus Histoplasma, at a 1:1
ratio. The results are representative of 6 independent experiments. ,
indicates that the measured value was below the detection limit of the
assay (,20 pg/ml). Error bars represent SD. *, P,0.001, paired Student’s
t test.
doi:10.1371/journal.pone.0012955.g001
IL-23 Regulates Virulence
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PLoS ONE | www.plosone.org 4 September 2010 | Volume 5 | Issue 9 | e12955TH-17 responses by human DCs are typically driven by IL-23,
but may also require, in particular at the initial stages of
differentiation other pro inflammatory cytokines, including IL1b
or IL1b plus IL-6 [19–23]. We found that IL-23 producing DCs
also secreted large amounts of IL-1b, which was dependent on
activation of dectin-1 as it was completely abolished in the presence
of dectin-1 neutralizing antibody (Figure S3A). In addition, IL-6
was also produced by IL-23 producing DCs, although its secretion
was only partially dependent on activation of dectin-1 (Figure S3B).
Notably, there was no significant reduction in IL-6 production by
Figure 3. Induction of IL-23 producing DCs by opportunistic fungal pathogens is dectin-1 dependent and is mediated by b-glucan.
(A) IL-23 production by human monocyte-derived DCs pre incubated for 1 h with increasing concentrations of the dectin-1 inhibitor laminarin (0, 0.01,
0.1, and 1 mg/ml) and subsequently stimulated with hyphae of either Aspergillus (open cycles) or Rhizopus (closed cycles), at a 1:1 ratio. (B) IL-23
production by DCs stimulated with hyphae of either Aspergillus (black bars) or Rhizopus (white bars), or b-glucan (scattered bars) or LPS (gray bars)
alone or following 1 h pre incubation with an anti-dectin-1 blocking antibody (10 mg/ml). Data are expressed as mean 6 SEM values for DCs derived
from three different donors. (C) Representative confocal microscopy images of b-glucan surface staining in hyphae of Aspergillus or Rhizopus
untreated or following overnight enzymatic digestion with b-glucanase (10 U/ml). (D) IL-23 production by DCs stimulated with hyphae of Aspergillus
(white bars) or Rhizopus (black bars) untreated or following overnight enzymatic digestion with b-glucanase. Data shown are representative of 3
independent experiments. Error bars represent SD. *, P,0.001, paired Student’s t test.
doi:10.1371/journal.pone.0012955.g003
Figure 2. The invasive form of opportunistic fungal pathogens but not that of pathogenic fungi exposes b-glucan in the cell wall
surface. Representative confocal microscopy images of b-glucan surface staining of resting (spores) and invasive (hyphae) stages of growth of the
opportunistic fungi Aspergillus or Rhizopus and the invasive (yeast) form of the pathogenic fungus Histoplasma. Live fungal cells were fixed with 1%
paraformaldehyde and stained with a mouse b-(1–3)-glucan-specific monoclonal antibody followed by staining with a secondary goat anti-mouse
Alexa488 antibody (green). The antibody failed to detect surface b-glucan on the spores of opportunistic fungi and in the invasive form of
Histoplasma but detected high amounts of the polysaccharide in germinating hyphae of both Aspergillus and Rhizopus (left panels). The overlay
images (DIC/b-glucan immunostaining; right panels) indicate the pattern of surface b-glucan staining in the different stages of growth of fungi. Data
shown are representative of 3 independent experiments.
doi:10.1371/journal.pone.0012955.g002
IL-23 Regulates Virulence
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addition of polymyxin-B (PMX-B) (Figure S5), thus excluding LPS
contamination in DC cultures.
The addition of neutralizing antibodies against IL-23 inhibited
IL-17 production by naı ¨ve and memory CD4
+ T cells polarized
with Aspergillus-stimulated DCs close to the baseline levels
(Figure 5C). Importantly, neutralizing antibodies against IL-23
did not affect IFN-c production by CD4
+ T cells polarized with
Aspergillus-stimulated DCs (Figure 5C). Therefore, IL-23 producing
DCs induced by hyphae of opportunistic fungi drive TH-17
responses.
Discussion
The emergence of life-threatening infections caused by airborne
opportunistic fungal pathogens in an expanding population of
non-neutropenic patients with defects in T-cell function, such as
transplant recipients, patients with autoimmune diseases receiving
biologic therapies or corticosteroids, and individuals with AIDS
[1,2], illustrates the pivotal role of adaptive immunity in antifungal
host defense.
Recent studies in mice demonstrate that the newly identified
TH-17/IL-23 axis regulates epithelial host defense against a
growing list of fungi [10–14]. In view of the considerable
differences in generation and function of TH-17 cells between
mice and humans [8,9], understanding the regulatory mechanisms
for induction of antifungal TH-17 responses in humans is
important for development of targeted therapeutic strategies.
Although purified b-glucan acts as a potent adjuvant for the
induction of IL-23 producing DCs and TH-17 priming [26], the
structural complexity and differential cellular composition of
various fungi makes it difficult to predict whether, which, and how
common molecular patterns in cell wall of different fungi link
innate sensing by DCs with TH-17 pathway induction. Herein, we
identified a common innate sensing pathway in human DCs that is
triggered by opportunistic fungi. We found that this pathway was
dependent on activation of dectin-1 signaling by b-glucan exposure
in the hyphae of opportunistic fungal pathogens, and resulted in
robust induction of IL-23 producing DCs that primed TH-17
antifungal responses. Importantly, we also demonstrated that
pathogenic fungi evade TH-17 induction by concealing immunos-
timulatory b-glucans with other polysaccharide layers and thus
avoiding activation of dectin-1 signaling.
Our initial studies identified that the signature cytokine of the
TH-17 pathway, IL-23, was selectively produced by human DCs
infected with hyphae of Aspergillus or Rhizopus, by not by DCs
infected with dormant spores of opportunistic fungi or the yeast
form of the pathogenic fungus Histoplasma. Importantly, we found
that generation of these IL-23 producing DCs correlated with
selective b-glucan surface exposure in the hyphae of Aspergillus and
Rhizopus. This was an unexpected finding based on biochemical
studies that failed to identify b-glucan in the cell wall of Rhizopus
(36), and clinical evidence of lack of detectable amounts of b-
glucan release in human infections caused by this fungus [4,5].
Our results corroborate with recent studies that identified b-glucan
synthetase, the enzyme responsible for synthesis of b-glucan, in
Rhizopus [40]. Next, by using specific dectin-1 inhibitors and b-
glucan enzymatic digestion, we confirmed that induction of IL-23
producing DCs is dependent on activation of dectin-1 signaling and
is mediated by b-glucan exposure in the hyphae of opportunistic
fungi. Importantly, surface exposure of b-glucan in the Dags1
mutant of Histoplasma that lacks the upper layer of a-glucan, not
only abrogated its virulence, but also triggered the induction of IL-
23 producing DCs via activation of dectin-1 signaling.
Our study is the first to explore the interaction of DCs with
fungi of the class Zygomycetes and the regulatory mechanisms of
TH-17 induction against airborne opportunistic fungi in humans.
Figure 4. Enforced b-glucan surface exposure in the non-
pathogenic Histoplasma Dags1 mutant drives IL-23 producing
DCs. (A) Representative confocal microscopy images of b-glucan
surface staining in yeast cells in the Dags1 mutant of Histoplasma and
the isogenic complementary strain Ags1 + (left panel). Overlay images
indicate the pattern of surface exposure on yeast cell surface (DIC/b-
glucan immunostaining; right panel). (B) IL-23 production by DCs
stimulated with the isogenic complementary strain Ags1+ of Histoplas-
ma and the Dags1 mutant untreated or following overnight enzymatic
digestion with b-glucanase (10 U/ml). IL-23 was selectively produced
following stimulation of DCs with Dags1 mutant. Data are expressed as
mean 6 SEM values of four independent experiments. *, P,0.001,
paired Student’s t test.
doi:10.1371/journal.pone.0012955.g004
IL-23 Regulates Virulence
PLoS ONE | www.plosone.org 6 September 2010 | Volume 5 | Issue 9 | e12955Figure 5. IL-23 producing DCs induced by opportunistic fungi drive Th17 responses. (A) IL-17 and IFN-c production determined by ELISA
in memory T cell cultures primed for 5 d in plates coated with anti-CD3 and anti-CD28, in the presence of supernatants (sups) of unstimulated DCs, or
sups of DCs stimulated with either Aspergillus spores, or hyphae (above plots), and then re-stimulated for 24 h with anti-CD3 and anti-CD28. Data are
expressed as mean 6 SEM values for DCs derived from six different donors. (B) Intracellular cytokine staining for IL-17 and IFN-c in memory CD4
+ T
cells primed and expanded as described in (A), and re-stimulated for 5 h with PMA and ionomycin. (C) ELISA of IL-17 and IFN-c in 24-hour culture
supernatants (sups) of naive and memory CD4
+ T cells primed for 5 d in plates coated with anti-CD3 and anti-CD28, in the presence of sups of
unstimulated DCs or Aspergillus spores-stimulated DCs or Aspergillus-hyphae stimulated DCs alone or in the presence of neutralizing anti-IL-23
antibodies. Data shown are representative of 5 independent experiments. Error bars represent SD. *, P,0.001, paired Student’s t test.
doi:10.1371/journal.pone.0012955.g005
IL-23 Regulates Virulence
PLoS ONE | www.plosone.org 7 September 2010 | Volume 5 | Issue 9 | e12955In agreement to our findings, a recent study reported that dormant
spores of Aspergillus were immunologically inert and did not induce
DC or alveolar macrophage activation, because of the presence of
a surface ‘rodlet layer’, composed of the hydrophobic RodA
protein that masks underlying immunostimulatory molecules [41].
Previous studies suggested that coordinated activation of TLR-2
and TLR-4 by Aspergillus spores triggers a TH-1 protective
response, whereas Aspergillus hyphae trigger TLR-2 activation
and a TH-2 response [6,24]. Nonetheless, studies using different
TLR and MyD88 knockout mice failed to convincingly show
increased susceptibility to Aspergillus infection in the absence of
immunosupression [7]. In contrast, dectin-1 knockout mice, display
increased susceptibility to invasive aspergillosis without the need
for administration of immunosuppressive agents, significantly
attenuated proinflammatory response and decreased IL-17
production in the lung [14]. Notably, in agreement to our finding,
macrophages from dectin-1 knockout mice fail to produce
proinflammatory cytokines in response to Aspergillus infection
[14]. Nonetheless, we cannot preclude that other immunostimu-
latory molecules on the fungal cell wall are selectively exposed
during invasive fungal growth to trigger PRRs in human DCs
[42–44]. Likewise, collaborative activation of dectin-1 with surface
TLRs and/or other PRR may be implicated in innate sensing of
different opportunistic fungi [45,46].
The induction of IL-23 producing DCs by different microbial
ligands is a key driver of TH-17 responses [8,9,19,23]. The ability
of dectin-1 when compared to other PRRs for preferentially
induction of IL-23 over IL-12, may be related to activation of a
noncanonical NF-kappaB signaling pathway mediated by the
serine-threonine kinase Raf-1 [47]. Indeed, supernatants from IL-
23 producing DCs generated by stimulation with Aspergillus hyphae
or b-glucan induced the production of IL-17 in naive human
CD4
+ T cells and a robust expansion of IL-17 producing memory
human CD4
+ T cells stimulated polyclonally. Notably, IL-17
production was significantly reduced by an antibody neutralizing
IL-23, as also suggested by other studies [19,21–23].
Overall, our studies demonstrate the important role of dectin-1
signaling as a major innate sensing pathway for induction on TH-
17 antifungal responses in humans. It is plausible that dysregu-
lation of this pathway in patients with underlying immunodefi-
ciency leads to unrestricted growth of opportunistic fungi and the
development of life-threatening infections. Therefore, targeting
this pathway for immunotherapy is an appealing strategy for
prevention and treatment of patients at increased risk for
development of opportunistic fungal infections. Future studies on
the function of dectin-1/TH-17 axis in immunocompromised
individuals might also provide a tool for risk stratification for
development of fungal infections.
Materials and Methods
Reagents
Highly purified Escherichia coli LPS, laminarin from Laminaria
digitata, and b-1,3-D-glucanase from Helix pomatia were obtained
from Sigma-Aldrich (St. Louis, MO). Purified particulate b-glucan
(curdlan) was from Waiko (Tokyo, Japan). b-(1-3)-glucan-specific
monoclonal antibody was from Biosupplies (Parkville, Australia).
Blocking monoclonal antibodies for dectin-1 (MAB1859, clone
259931; 10 mg/ml) and appropriate isotype control antibodies
were from R&D Biosystems. Neutralizing antibodies for the IL-23
p19 subunit (AF1716; 10 mg/ml), and IL-4 (34019; 10 mg/ml)
were from R&D Biosystems. Neutralizing antibodies for IFN-c
(B27; 10 mg/ml) were from BD Biosciences.
Microorganisms and culture conditions
The Aspergillus fumigatus strain Af293 and the Rhizopus oryzae
clinical isolate 557969 were grown on YAG-chloramphenicol agar
plates for 3 days at 37uC. Fungal spores in the presence of sterile
0.1% Tween 20 in PBS were harvested by gentle shaking, washed,
filtered, counted by a hemacytometer, and suspended at a
concentration of 10
8 spores/ml. Germinating hyphae of Aspergillus
and Rhizopus were obtained following growth in liquid RPMI 1640
media in a shaking incubator (220 rpm, 37uC), for 12 h and 8 h,
respectively. Typically, .80% of conidia of each fungus were
visibly swollen after 5 h.
Enzymatic digestion of b-glucan in the hyphae of Aspergillus and
Rhizopus was performed by using b-1-3-D-glucanase from Helix
pomatia (Sigma). Hyphae of both fungi were incubated overnight in
a shaking bath with 10 U/ml of b-glucanase at a temperature of
55uC and pH 5, 0. Inactivation of enzyme was achieved by
10 min incubation at 100uC followed by three washes in PBS.
Verification of b-glucan digestion was performed by immuno-
staining with a b-glucan monoclonal antibody.
H. capsulatum Dags1 mutant and its isogenic complementary
strain AGS1 (+) were derived from the clinical isolate G186A
(ATCC 26029) and have been described in ref 39. Histoplasma
yeasts were grown at 37uC with 95% air/5% CO2 in HMM
supplemented with 100 mg/ml uracil. Dispersed Histoplasma yeasts
were obtained by growth of liquid cultures to late exponential
phase, removal of large yeast clumps by low-speed centrifugation
(60 s at 1006g), three washes with Ham’s F-12 (Invitrogen,
Carlsbad, CA), and counting with a hemacytometer.
Inactivation of fungi was done by heat exposure (30 min, 65 C)
or exposure to 1% paraformaldehyde (4uC, overnight). In initial
DC stimulation experiments, amphotericin B (1 mg/ml) was added
to the cell cultures immediate after infection with fungi to prevent
germination or restrict overgrowth of germinating hyphae.
Because there were no appreciable differences in cytokine
production as compared to infection of DCs with inactivated
fungi, all following studies were performed with inactivated fungal
cells.
Generation of monocyte-derived DCs
This study was approved by the Institutional Review Board for
human research at the M. D. Anderson Cancer Center in
Houston. Separation of peripheral blood mononuclear cells
(PBMCs) was performed by density gradient centrifugation using
ficoll hypaque (Amersham Pharmacia Biotech, Uppsala, Sweden)
from healthy donor blood obtained from the Gulf Coast Regional
Blood Center, Houston, Texas. CD14
+ cells were enriched from
the PBMCs using CD14 microbeads and columns (Miltenyi
Biotec, Auburn, CA). In order to generate DCs, CD14
+ cells were
cultured in the presence of IL-4 (100 ng/mL; R&D Systems,
Minneapolis, MN) and granulocyte-macrophage colony-stimulat-
ing factor (GM-CSF; 100 ng/mL R&D Systems, Minneapolis,
MN) for 5 days at 2610
6 cells/ml in RPMI 1640 supplemented
with2 mM L-glutamine, 1 mM sodium pyruvate, 10 mM HEPES,
100 U/ml penicillin, 100 mg/ml streptomycin, and 10% FCS (v/
v). On day 5 the cells were 70 to 90% CD1a
+ and 95% CD14
2.
Then the culture medium containing IL-4 and GM-CSF was
replaced with culture medium alone 2 h before infection with
fungi or other treatments.
Purification of naive and memory CD4
+ T lymphocytes
from adult blood
Untouched naı ¨ve and memory CD4
+ T lymphocytes were
purified from PBMCs by immunomagnetic depletion with the
IL-23 Regulates Virulence
PLoS ONE | www.plosone.org 8 September 2010 | Volume 5 | Issue 9 | e12955naı ¨ve CD4
+ T Cell Isolation Kit II and memory CD4
+ T Cell
Isolation Kit (Miltenyi Biotec), respectively. Naive CD4
+ T cells
(CD3
+CD4
+CD45RA
+CD45RO
2) typically had a purity of over
95%, as evidenced by flow cytometry. For some experiments,
peripheral blood CD4
+ T cells were isolated with the CD4
+ T Cell
Isolation Kit II (Miltenyi Biotec), followed by staining with APC-
CD45RO
+, FITC-CD45RA+, PE-Cy5-CD4
+, and PE-labeled
lineage mixture antibodies against CD8, CD14, CD16, CD19,
CD56, CD11c, cd-TCR, CD11c, CD25, and BDCA-2, and were
sorted into two fractions of CD4
+CD45RO
+CD45RA
2 and
CD4
+CD45RA
+CD45RO
2 with cell purity over 99%, on a
FACSAria (BD Bioscience).
Stimulation of monocyte-derived DCs
Monocyte-derived DCs were seeded at a final concentration of
10
6 cells per ml in RPMI culture medium in flat-bottomed 24-well
plates (Falcon). Spores or hyphae of each opportunistic fungus or
yeast cells of each strain of Histoplasma were counted, and added to
DC cultures at a final concentration of 10
6 cells per ml (1:1 E:T
ratio). In order to normalize for the amount of spores and hyphae
that were co-cultured with DCs and minimize the effects of the
increased fungal biomass of hyphae, we used early germinating
hyphae (fig. 2) instead of mature, branching hyphae. In pilot
experiments, increasing the amount of dormant spores to 1:10 or
1: 20 didn’t have a significant effect on the type and amount of
pro-inflammatory cytokines produced by DCs. Stimulation of DCs
was also induced in flat-bottomed 24-well plates by adding purified
b-glucan (curdlan; 100 mg/ml), or LPS (100 ng/ml). For receptor
blocking experiments DCs were pre incubated with blocking
antibodies for dectin-1, or the corresponding isotype control
antibody for 1 h before treatment with fungi or other stimuli.
T cell stimulation
Naı ¨ve and memory CD4
+ T cell subsets were cultured in flat-
bottomed 96-well plates (Falcon) in Yssel’s medium supplemented
with 2 mM L-glutamine (GIBCO-Invitrogen), 1 mM sodium
pyruvate (GIBCO-Invitrogen), 10 mM HEPES (GIBCO-Invitro-
gen),100 U/ml penicillin, 100 mg/ml streptomycin (GIBCO-
Invitrogen), and 10% FCS (v/v; GIBCO-Invitrogen), at a density
of 5610
4 cell per well, and stimulated with plate-bound anti-CD3
(10 mg/ml) and soluble anti-CD28 (1 mg/ml) in the presence of
supernatants from unstimulated or variously stimulated monocyte-
derived DCs. For some experiments with naı ¨ve CD4
+ T cells, anti-
IFN-c and anti-IL-4 were added to the cultures at a concentration
of 10 mg/ml. After 5–6 days cells were collected and washed
extensively and their viability was determined by trypan blue
exclusion. Cells (1610
6 cells/ml) were restimulated with PMA
(50 ng/ml; Sigma) and Ionomycin (500 ng/ml; Sigma) for 6 h (for
flow cytometry intracellular staining) or in the presence of anti-
CD3 and anti-CD28 for 24 h (for ELISA).
Analysis of cytokine production
Supernatants of stimulated DCs or T cells were collected after
overnight culture. Cytokine levels in the supernatants were
determined by using ELISA kits for human IL-1b, IL-6, IL-12,
IL-17, IFN-c (R&D systems), and IL-23 ELISA (eBioscience)
according to the manufacturer’s instructions. Cells producing IFN-
c and IL-17 were analyzed by intracellular cytokine staining after
the addition of GolgiStop (10 mg/ml; BD Biosciences) during the
final 4 h of restimulation. Cells were made permeable with
Cytofix/Cytoperm reagents (BD Biosciences). Cells were stained
with FITC-anti-IFN-c (4S.B3; BD Pharmingen) and PE-anti-IL-
17 (eBio 64DEC17; eBioscience) and washed and then were
analyzed by flow cytometry (FACSCalibur; BD Biosciences).
Confocal imaging studies
Live spores or hyphae of opportunistic fungi and yeast cells of
Histoplasma were fixed with 4% paraformaldehyde, pelleted in
propylene tubes, washed twice with PBS, blocked for 30 min in
PBS plus 1% goat serum, incubated for 1 h with a mouse
monoclonal antibody to linear-(1,3)-b-glucan (Biosupplies; 1 mg/
ml), washed twice in PBS plus 1% goat serum and stained by a
secondary AlexaFluor 488 goat anti-mouse Ab (Molecular probes).
Images of PFA-fixed fungal cells were acquired using a Leica SP2
RS laser-scanning confocal microscope with an oil-immersion
objective (Leica 663/1.4 numerical aperture) using identical gain
settings at room temperature. The AlexaFluor 488 goat anti-
mouse Ab used as flurochrome was excited with an Argon Laser.
Images were collected using LCS V2.61 software (Leica Micro-
systems, GmbH) and processed with Adobe Photoshop CS2.
Statistics. A standard two-tailed t-test or a t-test with Welch’s
correction was applied for statistical analysis by using the
GraphPad Prism software. P values of 0.05 or less were con-
sidered significant.
Supporting Information
Figure S1 TH-17 polarizing cytokines are preferentially induced
by fungal hyphae in human DCs. IL-1b (A) IL-6 (B) and TNF-a
produced by human monocyte-derived DCs (1610^6 cells per ml)
following overnight stimulation with purified b-glucan (curdlan,
100 mg/ml), resting (spores) or invasive (hyphae) stages of growth
of each opportunistic fungus (Aspergillus and Rhizopus) at a 1:1
ratio. Data are expressed as mean 6 SEM values for DCs derived
from three different donors. *, P,0.001, paired Student’s t test.
Found at: doi:10.1371/journal.pone.0012955.s001 (1.08 MB TIF)
Figure S2 Dectin-1 inhibitor laminarin has no effect on DC
activation by TLR ligands. IL-23 production by human monocyte-
derived DCs pre incubated for 1 h with increasing concentrations
of the dectin-1 inhibitor laminarin (0, 0.01, 0.1, and 1 mg/ml) and
subsequently stimulated with LPS (100 ng/ml). Data shown are
representative of 2 independent experiments.
Found at: doi:10.1371/journal.pone.0012955.s002 (3.21 MB TIF)
Figure S3 TH-17 polarizing cytokines are preferentially induced
by fungal hyphae in human DCs. IL-1b (A), IL-6 (B), and IL-12
(C) production by DCs stimulated with hyphae of Aspergillus
(white bars) or Rhizopus (black bars), or b-glucan (scattered bars)
or LPS (gray bars) with (+) or without (2) pre incubation for 1 h
with an anti-dectin-1 blocking antibody (10 mg/ml). Data are
expressed as mean 6 SEM values for DCs derived from three
different donors. *, P,0.001; **, P,0.05 paired Student’s t test.
Found at: doi:10.1371/journal.pone.0012955.s003 (4.87 MB TIF)
Figure S4 Aspergillus hyphae drive the expansion of IL-17
producing memory CD4+ T cells. Flow cytometry to determine
the percentage of cells producing IL-17 and IFN-c among
memory CD4+ T cells primed for 5 d in plates coated with
anti-CD3 and anti-CD28, in the presence of supernatants of
unstimulated DCs, or supernatants of DCs stimulated with either
Aspergillus spores, or hyphae (above plots), and re-stimulated for
5 h with PMA and Ionomycin. Data are expressed as mean 6
SEM values for DCs derived from five different donors.
Found at: doi:10.1371/journal.pone.0012955.s004 (4.54 MB TIF)
Figure S5 Polymyxin B has no effect in IL-6 production by DCs
activated with b-glucan or fungal hyphae. IL-6 production by DCs
stimulated with hyphae of Aspergillus (white bars) or b-glucan
(black bars scattered bars) or LPS (gray bars) with or without pre
incubation for 10 min with increasing concentrations of polymyx-
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2 independent experiments.
Found at: doi:10.1371/journal.pone.0012955.s005 (5.19 MB TIF)
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